The Patent Finder

Terms ending in 2027

Gilead Sciences, Inc.

Every in-force patent on Gilead Sciences, Inc.'s record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 7,956,179Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,106,183Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US 8,268,988Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US 8,524,883Monohydrate of (1-{9-[(4S,2R,3R,5R)-3,4-Dihydroxy-5-(HYDROXYMETHYL)OXOLAN-2-YL]-6-Aminopurin-2-YL}PYRAZOL-4-YL)-N-METHYLCARBOXAMIDE
In force
 · Medium confidence
Gilead Sciences, Inc.In forceMedium confidence
US RE47,301Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs
In force
 · Low confidence
Gilead Sciences, Inc.In forceLow confidence
US 8,431,745Process for Preparation of HIV Protease Inhbitors
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 7,671,192Process for Preparing an A2A-ADENOSINE Receptor Agonist and Its Polymorphs
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,609,671Method of inhibiting hepatic fibrosis as a result of liver replacement or repair using A2B adenosine receptor antagonists
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,188,099Method of Decreasing Hepatotoxic Side Effects Using A2B Adenosine Receptor Antagonists
In force
 · High confidence
Gilead Sciences, Inc.In forceHigh confidence
US 8,435,969Method and Compositions for Treating Hematological Malignancies
In force
 · High confidence
Vetdc IP, LLCIn forceHigh confidence
18 more term ends in 2027 · Pro
10 of 28 patents shown. Soonest term end first, then patent number.
Pro members see all 28, all of them expiring within the 18 months from Nov 17, 2026.
Upgrade to Pro
25 of these are in force and held by Gilead Sciences, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited